NetworkNewsBreaks

MondayNov 14, 2016 11:56 am

Acquisition Strategy Sets Medical Transcription Billing Corp. (MTBC) on Pace for Incremental Profits

Recently posting its fourth straight quarter of positive adjusted EBITDA and another quarter of YoY revenue growth, healthcare IT company Medical Transcription Billing, Corp. (NASDAQ: MTBC) (NASDAQ: MTBCP) is demonstrating increased momentum of its aggressive acquisition-based strategy.  The company most recently acquired Texas-based medical billing company MediGain, LLC, including substantially all of its assets and its subsidiary, for $7 million. “In total, the accounts in good standing acquired through this transaction have annual revenues in excess of $10 million … the MediGain acquisition is expected to be accretive to MTBC shareholders in 2017, as incremental profits are expected to greatly…

Continue Reading

FridayNov 11, 2016 1:42 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on November 11, 2016

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: IMTL 11.10% - News: Collaboration integrates technologies to protect 50 million images DPDW 18.75% - News: Turns to profit in Q3, increases sales GRNH 17.87% - News: Unveils cannabis extraction labs, announces 2017 launch of CBD nutraceutical products MCAP 14.29% - News: Auctioning properties to raise cash and issue dividend EAC 4.18% - News: Bankruptcy Court approves first day motions for Chapter 11 restructuring CLBS 8.17% - News: Q3 revenues increase 58% to $9.3M…

Continue Reading

FridayNov 11, 2016 1:13 pm

Genocea Biosciences, Inc. (GNCA): ATLAS™ Study Demonstrates Potential for Personalized Cancer Vaccines; Shares Climb

Genocea Biosciences (NASDAQ: GNCA) is trading higher after the developer of cell-directed vaccines and immunotherapies reported data supporting the potential of its proprietary antigen identification screening system, ATLAS™, to identify personalized neoantigens that could guide development of neoantigen vaccines. Conducted in collaboration with Memorial Sloan Kettering Cancer Center (MSK), the study analyzed neoantigens in one non-small cell lung cancer patient successfully treated with pembrolizumab (KEYTRUDA®). Data will be presented at the Society for Immunotherapy of Cancer’s (SITC) 31st Annual Meeting & Associated Programs on November 12, 2016. To view the full press release, visit: http://nnw.fm/op5sS About Genocea Genocea is harnessing…

Continue Reading

FridayNov 11, 2016 1:11 pm

Towerstream Corp. (TWER) Increases Q3 Adjusted EBITDA; Shares Higher

Shares of Towerstream (NASDAQ: TWER) are higher in late-morning trade, driven by third-quarter guidance for Adjusted EBITDA from Continuing Operations of $525,000 excluding non-recurring expenses. Among other notes, the company reported a reduction in long-term debt to $32 million from $37 million. A conference call to discuss results for the third quarter 2016 will be held November 16, 2016 at 5 p.m. ET. To view the full press release, visit: http://nnw.fm/vKlW9 About Towerstream Corporation Towerstream Corporation (TWER) is a leading Fixed-Wireless Fiber Alternative company delivering high-speed Internet access to businesses. The Company offers broadband services in 12 urban markets including New York City, Boston,…

Continue Reading

FridayNov 11, 2016 1:10 pm

GainClients, Inc. (GCLT) Targets Emerging Digital Trends in Real Estate Industry

GainClients’ (OTC: GCLT) progressive GCard networking system enables agents and brokers the ability to offer real estate, lending and title services information through an integrated, web-based network, capitalizing on the ongoing shift in consumer preference toward mobile solutions. As the company pursues avenues to expand the reach of its GCard network, it employs a growth strategy supported by key industry partnerships and licensing arrangements. “Strategic partnerships are an important component of GainClients’ growth strategy. The company recently established a worldwide licensing arrangement with CLOVIS LLC, a partnership that will enable the distribution of both companies’ proprietary technologies to the real…

Continue Reading

FridayNov 11, 2016 1:08 pm

Medical Transcription Billing, Corp. (MTBC) Provides Essential Element of Broader Health Care Initiatives

Considered by some to be the most important piece of health care reform in three decades, The Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009, among other things, encouraged the use of electronic health records (EHR) to significantly improve medical services. Integrated charting services are a core part of Medical Transcription Billing, Corp.’s (NASDAQ: MTBC) (NASDAQ: MTBCP) proprietary HER technology, ChartsPro, which makes the delivery of service more efficient and enables practitioners to reach ‘Meaningful Use’ standards set forth by HITECH. “MTBC’s charting services are designed to help physicians generate accurate, timely patient charts and better…

Continue Reading

ThursdayNov 10, 2016 2:40 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on November 10, 2016

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: GALT 35.08% – News: Announces positive interim clinical data for GR-MD-02 for the treatment of skin disease ETRM 33.20% – News: Posts Q3; net loss of $6.5 million, $0.17 per share, on sales of $296,760 MVIS 22.60% – News: Partners with STMicroelectronics (NYSE: STM) to market Laser Beam Scanning technology RXII 14.72% – News: Trims Q3 net loss to $2.2 million from $2.5 million last year FCSC 16.38% – News: Names board-certified dermatologist and…

Continue Reading

ThursdayNov 10, 2016 2:04 pm

Imprimis Pharmaceuticals, Inc. (IMMY) Inks New Supply Agreement; Shares Climb

Imprimis Pharmaceuticals (NASDAQ: IMMY) is trading 11% higher mid-morning, driven by the company’s product purchase and supply agreement with the specialty pharmacy division of one of the nation's largest pharmacy benefit managers (PBMs) to supply Imprimis' complete formulary of low-cost compounded medications through the PBM's national network of specialty pharmacies. To view the full press release, visit: http://nnw.fm/Y7hHj About Imprimis Pharmaceuticals Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative compounded medications in all 50 states.  The company's unique business model drives patient access and affordability to many critical medicines.  Headquartered in…

Continue Reading

ThursdayNov 10, 2016 10:58 am

Galectin Therapeutics, Inc. (GALT) Shares Surge on Positive Interim Data for Lead Candidate GR-MD-02

Shares of Galectin Therapeutics (NASDAQ: GALT) are up more than 30% this morning after delivering positive interim clinical data for its lead candidate GR-MD-02 to treat psoriasis and atopic dermatitis. The company also announced its plans to identify a strategic partnership to further develop the drug candidate for the treatment of serious skin diseases. To view the full press release, visit: http://nnw.fm/d95Ap About Galectin Therapeutics Galectin Therapeutics is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin proteins, which are key mediators of biologic function. Galectin seeks to…

Continue Reading

ThursdayNov 10, 2016 10:55 am

Moxian, Inc. (MOXC) Solutions Help Merchants Build Strong Customer Relationships to Keep Competitive Edge

Customer satisfaction is a bedrock for any organization, and the most successful businesses are the ones who dedicate time to cultivate customer-merchant relationships. By listening to consumers, engaging in ongoing communication, rewarding loyalty, and efficiently training employees, businesses are privy to repeat business and word of mouth marketing. While social media creates a wealth of opportunity to build customer relationships, it takes considerable time, knowledge and dedication to pull-off a successful campaign. “Businesses, especially small businesses, are looking to creative outside marketing services to better interact with their consumers. Moxian, Inc. (OTCQB: MOXC) offers exactly such services and more. MOXC…

Continue Reading